Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer
Brennah Murphy(The Wistar Institute), Nan Zhang(Washington University in St. Louis), Gauri Mirji(The Wistar Institute), Andrew V. Kossenkov(The Wistar Institute), Filippo Veglia(Moffitt Cancer Center), Yanfang Peipei Zhu(University of California San Diego), Lu Huang(Jiangnan University), Rahul Shinde(The Wistar Institute), Taito Miyamoto(The Wistar Institute), Toshitha Kannan(The Wistar Institute), Daniel T. Claiborne(The Wistar Institute), Rugang Zhang(The University of Texas MD Anderson Cancer Center), Bryan Manning(The Wistar Institute), Alessio Ugolini(The Wistar Institute), Kohei Hamada(Kyoto University), Yulia Nefedova(The Wistar Institute)
Cited by 15
Related Papers
Mechanism of All- <i>Trans</i> Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells
|Cancer Research|2007|416
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
|Nature|2018|408
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|347
Update of TTD: Therapeutic Target Database
|Nucleic Acids Research|2009|277